In another approach, EGFR-targeting exosomes have been generated by displaying anti-EGFR nanobodies or peptides on their surface, enabling selective delivery to EGFR-overexpressing head and neck squamous cell carcinoma cells [86]. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.